Julian Baker, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), bought 98,774 shares at $156.42 ($15.6M) on 2023-11-14, disclosed to the SEC on 2023-11-15.
Open-market purchase of $15.6M MDGL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.42 | 2,658 | $416K | 2.7% |
| 2 | $156.42 | 2,658 | $416K | 2.7% |
| 3 | $156.42 | 31,530 | $4.9M | 31.6% |
| 4 | $156.42 | 31,530 | $4.9M | 31.6% |
| 5 | $161.97 | 1,181 | $191K | 1.2% |
| 6 | $161.97 | 1,181 |
| $191K |
| 1.2% |
| 7 | $161.97 | 14,018 | $2.3M | 14.5% |
| 8 | $161.97 | 14,018 | $2.3M | 14.5% |
| Total | $158.13 avg | 98,774 | $15.6M | 100% |
| Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| IGMS | BUY | 2023-06-28 | $45.0M | — | Filing → |
| INCY | BUY | 2022-02-14 | $213.5M | — | Filing → |